proposed that p53 can directly bind to the lincRNA-p21 promoter and inhibit its expression, thus down-regulating the JAK2/STAT3 signaling pathway and subsequently inhibiting the progression of HNSCC (34). The gene discussed is JAK2; the disease is head and neck squamous cell carcinoma.